US proposes curbs on investment in Chinese biotech firms
This comes at a time when US drugmakers are increasingly turning to China for new medicines
We haven't written up this one. The Business Times - Companies & Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.